Time |
Program |
Speaker |
09:00-09:15 |
Registration |
|
Session 7 |
Free Communication |
You Chan Kim Ajou Univ. |
09:15-09:25 |
Exploring neuro-immune interaction in Candida albicans-induced itch mouse model |
Alina Tyo Yonsei Univ. |
09:25-09:35 |
Characterization of Circulating Classical Monocytes in Atopic Dermatitis through Single-Cell RNA Sequencing |
Yujin Lee Catholic Univ. |
09:35-09:45 |
Gene Expression Signatures and Functional Pathway Dysregulation in Lesional Skin of Atopic Dermatitis |
Nadyatul Husna Rumah Sakit Dr. Reksodiwiryo Military Hospital Padang |
09:45-09:55 |
Childhood Antibiotic Exposure, Obesity, Weight Changes, and the Risk of Atopic Dermatitis |
Seong Rae Kim Seoul National Univ. |
09:55-10:05 |
Assessing atopic dermatitis control in Chinese patients: validation of the Chinese version of Recap of atopic eczema questionnaire (RECAP) and an investigation into its interpretability |
Junfen ZhangSouthern Medical Univ. |
10:05-10:15 |
Clinical Characteristics of Hand Eczema in Atopic Dermatitis Patients Treated with Dupilumab: A Case Series and Patch Test Findings |
Jung U Shin Cha Univ. |
10:15-10:30 |
Coffee Break |
|
Session 8 |
Unveiling Neuroimmune Pathways: Itch Mechanisms and Therapeutic Advances |
Moon-Bum Kim Pusan National Univ. |
10:30-11:15 |
Neuroimmune interactions in skin diseases |
Fang Wang Dermatology Hospital, Southern Medical Univ. |
11:15-11:40 |
Anoctamin 1 expressed in pruritoceptors is essential for Mas-related G-protein receptor dependent itch |
Uhtak Oh Korea Institute of Science and Technology |
11:40-12:00 |
Novel insights and new treatments in prurigo nodularis |
Yong Hyun Jang Kyungpook National Univ. |
Session 9 |
Luncheon Symposium |
Jee-Bum Lee Chonnam Univ. |
12:00-12:40 |
Explore Ebglyss: A new IL-13 era for atopic dermatitis with real-world experience |
Marni Charlotte Wiseman Univ. of Manitoba |
Session 10 |
Evolving Standards in Atopic Dermatitis : From Diagnosis to
Outcome Measures |
Joo Young Roh Ewha Womans Univ. |
13:20-14:05 |
Measuring atopic dermatitis outcomes in research and clinical practice |
Hywel C Williams Univ. of Nottingham |
14:05-14:30 |
A new era in diagnosis : Exploring the 2023 Korean criteria for atopic dermatitis |
Jihyun Lee Catholic Univ. |
Session 11 |
Big Data and Digital Innovation in Atopic Dermatitis Care |
Sung Yul Lee Soonchunhyang Univ. |
14:30-14:55 |
Big data insights reshaping atopic dermatitis epidemiology and care |
Hye One Kim Hallym Univ. |
14:55-15:20 |
Digital biomarkers and interventions advancing atopic dermatitis management |
Young Joon Park Ajou Univ. |
15:20-15:35 |
Coffee Break |
|
Session 12 |
Novel Strategies in the Treatment of Atopic Dermatitis |
Young Wook Ryoo Keimyung Univ. |
15:35-16:15 |
Addressing unmet needs in atopic dermatitis : Tralokinumab, a promising therapeutic option for head and neck atopic dermatitis |
Constanza Riquelme Mc LoughlinHospital Clínic de Barcelona |
16:15-16:40 |
Recent advances of modulating the OX40-OX40L inhibition : The next game changer for atopic dermatitis? |
Hyun-Chang Ko Pusan National Univ. |
16:40-17:05 |
New and upcoming topical treatments : Results in better outcomes |
Sun Young Choi Chung Ang Univ. |
17:05-17:15 |
Group Photo and Closing Remark |
17:30-19:00 |
Dinner in the Section I of the Grand Ballroom |